Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Filings indexed 3,397 across all filing types
Latest filing 2019-07-12 Regulatory Filings
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
IMFINZI GRANTED US ORPHAN DRUG DESIGNATION FOR SMALL CELL LUNG CANCER
Regulatory Filings
2019-07-12 English
Imfinzi granted US Orphan Drug Designation for
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated 12 July 2019. The content is a press release announcing that the FDA granted Orphan Drug Designation (ODD) to Imfinzi for small cell lung cancer. It includes details about the drug, clinical trials, and company background. The footer explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This structure and source identification strongly indicate a general regulatory announcement disseminated via the RNS system, which corresponds to the 'Regulatory Filings' category (RNS), as it is not a specific financial report (like 10-K, IR, ER) or a meeting material.
2019-07-12 English
Update on Zegona's Strategy for Euskaltel
Board/Management Information Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details an update regarding board appointments at Euskaltel following a shareholders' meeting, which relates to corporate governance and management changes. However, the primary nature of the filing itself is a general regulatory announcement distributed via the RNS system. Since the content specifically concerns board appointments (Robert Samuelson's reappointment as a proprietary director), it strongly aligns with Board/Management Information (MANG). Given that RNS is the distribution channel and the core subject is management/board changes, MANG is the most specific classification, although RNS is also plausible as a fallback. I will prioritize MANG as the subject matter is clearly defined.
2019-07-11 English
FASENRA RECEIVES POSITIVE EU CHMP OPINION FOR SELF
Regulatory Filings
2019-07-01 English
TOTAL VOTING RIGHTS
Regulatory Filings
2019-07-01 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document explicitly states it is an 'RNS Number' notification from AstraZeneca PLC, dated 01 July 2019. The content concerns 'Voting Rights and Capital' as per the 'UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1', detailing the total number of voting rights (1,311,783,132). This is a standard regulatory disclosure regarding the company's capital structure and shareholder notification thresholds, which fits the definition of a general regulatory announcement. Since it is a specific regulatory filing that doesn't fit the more specific categories like DIV, DIRS, or SHA, the most appropriate general category is Regulatory Filings (RNS). The document length is short (3085 chars) and it is a direct notification, not an announcement of a larger report.
2019-07-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.